Valneva SE recently announced that the United Arab Emirates (UAE) granted Emergency Use Authorisation (EUA) for Valneva’s inactivated, adjuvanted COVID-19 vaccine.
This authorisation follows conditional marketing authorisation from the UK MHRA, which was granted last month, and EUA from the Bahraini NHRA in March 2022.